Cancer diagnostics maker Accustem files for Nasdaq uplisting, $11M offering Posted on January 21, 2023 By Charlielikes Stock Market
Cancer test developer Accustem seeks Nasdaq uplisting, $10M offering (update) Posted on November 18, 2022 By Charlielikes Stock Market